Department of Anaesthesia and Intensive Care, The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.
Br J Anaesth. 2012 Mar;108(3):452-9. doi: 10.1093/bja/aer449. Epub 2012 Jan 31.
Long-held assumptions of poor prognoses for patients with haematological malignancies (HM) have meant that clinicians have been reluctant to admit them to the intensive care unit (ICU). We aimed to evaluate ICU, in-hospital, and 6 month mortality and to identify predictors for in-hospital mortality.
A cohort study in a specialist cancer ICU of adult HM patients admitted over 5 yr. Data acquired included: patient characteristics, haematological diagnosis, haematopoietic stem cell transplant (HSCT), reason for ICU admission, and APACHE II scores. Laboratory values, organ failures, and level of organ support were recorded on ICU admission. Predictors for in-hospital mortality were evaluated using uni- and multivariate analysis.
Of 199 patients, median age was 58 yr [inter-quartile range (IQR) 46-66], 51.7% were emergency admissions, 42.2% post-HSCT, 51.9% required mechanical ventilation, median APACHE II was 21 (IQR 16-25), and median organ failure numbered 2 (IQR 1-4). ICU, in-hospital, and 6 month mortalities were 33.7%, 45.7%, and 59.3%, respectively. Univariate analysis revealed bilirubin >32 µmol litre(-1), mechanical ventilation, ≥2 organ failures, renal replacement therapy, vasopressor support (all P<0.001), graft-vs-host disease (P=0.007), APACHE II score (P=0.02), platelets ≤20×10(9) litre(-1) (P=0.03), and proven invasive fungal infection (P=0.04) were associated with in-hospital mortality. Multivariate analysis revealed that ≥2 organ failures [odds ratio (OR) 5.62; 95% confidence interval (95% CI), 2.30-13.70] and mechanical ventilation (OR 3.03; 95% CI, 1.33-6.90) were independently associated with in-hospital mortality.
Mortality was lower than in previous studies. Mechanical ventilation and ≥2 organ failures were independently associated with in-hospital mortality. 'Traditional' variables such as neutropenia, transplantation status, and APACHE II score no longer appear to be predictive.
长期以来,人们认为血液恶性肿瘤(HM)患者预后不佳,这导致临床医生不愿意将他们收治到重症监护病房(ICU)。我们旨在评估 ICU、住院和 6 个月死亡率,并确定住院死亡率的预测因素。
对一家癌症专科 ICU 中过去 5 年内收治的成年 HM 患者进行队列研究。收集的数据包括:患者特征、血液学诊断、造血干细胞移植(HSCT)、入住 ICU 的原因和急性生理学和慢性健康评估 II 评分(APACHE II)。记录 ICU 入院时的实验室值、器官衰竭和器官支持水平。使用单变量和多变量分析评估住院死亡率的预测因素。
199 例患者中,中位年龄为 58 岁[四分位间距(IQR)46-66],51.7%为急诊入院,42.2%为 HSCT 后,51.9%需要机械通气,中位 APACHE II 为 21(IQR 16-25),中位器官衰竭数为 2(IQR 1-4)。ICU、住院和 6 个月的死亡率分别为 33.7%、45.7%和 59.3%。单变量分析显示胆红素>32μmol/L(P<0.001)、机械通气、≥2 个器官衰竭、肾脏替代治疗、血管加压素支持(均 P<0.001)、移植物抗宿主病(P=0.007)、APACHE II 评分(P=0.02)、血小板≤20×10(9)/L(P=0.03)和确诊的侵袭性真菌感染(P=0.04)与住院死亡率相关。多变量分析显示≥2 个器官衰竭[比值比(OR)5.62;95%置信区间(95%CI),2.30-13.70]和机械通气(OR 3.03;95%CI,1.33-6.90)与住院死亡率独立相关。
死亡率低于既往研究。机械通气和≥2 个器官衰竭与住院死亡率独立相关。中性粒细胞减少症、移植状态和 APACHE II 评分等“传统”变量似乎不再具有预测性。